Ng Carey
CIK 0001889522
Director
Filings
7
Latest May 29, 2026
Issuers covered
1
Showing
7 of 7
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | +7.1% | +7.1% | +16.9% | -2.6% |
| 90 days | 2 | 50% | +24.7% | +24.7% | +64.2% | -14.7% |
| 180 days | 2 | 100% | +13.4% | +13.4% | +22.0% | +4.7% |
| 365 days | 2 | 50% | -2.9% | -2.9% | +21.1% | -26.8% |
Issuers
Companies where Ng Carey has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| IMMX | Immix Biopharma, Inc. | 7 | May 29, 2026 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|